Lorillard
Fields
- Author
- Homburger, F.
- Area
- SCHULTZ/BASEMENT GMP (VPRD)
- Type
- LETT, LETTER
- Alias
- 01197922/01197924
- Recipient
- Parmele, H.B.
- Named Person
- Bogdonoff
- Kelly
- Date Loaded
- 05 Jun 1998
- Document File
- 01197922/01198045/Bio Research 64 01-64 06
- Litigation
- Flag/Trial Exhibit 2106
- Morm/Trial Exhibit 1382
- Stmn/Produced
- Txag/Trial Exhibit 2106
- Morm/Trial Exhibit 1382
- Author (Organization)
- Bio, Bio Research Labs.,Bio Research Consultants
- Site
- G60
- Request
- R1-004
- R1-032
- R1-039
- R1-041
- R1-057
- R1-058
- R1-131
- R1-032
- Master ID
- 01197922/7958
Related Documents: - UCSF Legacy ID
- gsl88d00
Document Images
r '.
S
BIO -lRESEARCH CONSULTANTS, INC.
-~ CON!SUiLT'ATION
.
RESEARCH DEVELOPMENT
F. HOMBURGER, M, D: 9' COMMERCIAL AVENUE
P. BERNFELD; Ph.D. CAMBRIDGE 41;, MASSACHUSETTS
UNiversity 4-8735
June 26, 1964
Dr. H. B. Parmele, Vice President
Director of Research
P. Lorillard~ Company
200 East 42nd Street
New York, New York
0017
Dear Dr. Parmele:
This is to confirm our recent telephone conversation and to
congratulate you and your associates on your discovery that one of
the subfractions of fraction B contains 1, 1 dichlioro 2, 2 bis (p-
chlorophenyl) ethane (otherwise known as tetrachlorodiphenylethane,
(TDE), dichlorodiphenyl dichloroethane, (DDD); pp-TDE, rhotane
C14H10C14 (mp 109 to 110 degrees).
We note that this material is present in a concentration of 0.003°jo
of the total tar.
Since the first tumors in mouse sltin carcinogen studies appear
after some 40 weeks of painting of 35 mg of tar per week per mouse,
45y of' DDD would have been applied during the latent period. We
suggest that this be the basic dose chosen as the lowest level to be studied
for possible co-carcinogenic activity.
The quickest way to obtain an indication of the co-carcinogenic
effect of this material is to conduct the experiment which you have
authorized and which willi be started as soon as we shall receive the
DDD which has been ordered. This material will be recrystalized prior
to use and you will receive samples of the purified material such as we
shall inject into mice.

BIO-RESEARCH - 1/64 - 6/64
O~tq~~2-- C-t

1
Page 2
Dr. Parmele June 26, 1964
Five hundred C57 B/6 male mice will be used, kept ten per cage
in air-conditioned rooms and given purina chow and water ad lib.
They will be divided into five groups of 100 each and will receive the
following subcutaneous injections in 0. 5 ml of peanut oil,:
Group 1 500Y of 3, 4, 9, 10 dibenzpyrene
Group 2 500y of 3, 4, 9, 1'10 dibenzpyrene + 50Y DDD
Group 3 500Y of 3, 4, 9, 110 dibenzpyrene + 500Y DDD
Group 4 500y of 3, 4, 9, 110 dibenzpyrene + 5 mg of DDD
Gr oup 5 5 mg of DDD
The animals will be examined at frequent intervals by palpation,
and the appearance of palpable tumors of 1 cm diameter will be noted.
Some of these tumors in each group will be sectioned for histopathological
study to ascertain the malignant nature of the tissue reaction. In the
event that DDD itself alone should cause tumors, they would be transplanted
to ascertain their malignant nature by bio-assay.
In thousands of tumors which we have induced by 3, 4, 9, 1'0
dibenzpyrene (see attached reprints) none of the induced neoplasms
appeared before the eight'h week, and their rate of appearance i~s extremely
constant and reproducible.
The addYtion of 3°jo cholesterol to 3, 4, 9, 10 dibenzpyrene, for example,
has significantly increased the slope of this tumor appearance curve and
revealed the co-carcinogenic nature of cholesterol after about nine weeks
of' study.
If DDD is co-carcinogenic, we may expect to detect this within eight
to twelve weeks in, the present experiment. If it is a carcinogen this will
also become apparent, alt'hough: perhaps not until twenty weeks after the
start of the study.
We realize your desire to obtain an indication soon of the co-
carcinogenic or carcinogenic potency of DDD and are expediting this work
as much as possible. Dr. Bogdonoff made a literature search yesterday
which, failed to show any data on carcinogenesis and inforrnation only on
the interesting pharmacological properties of DDD which do not concern
us here.

l
Page 3
Dr. Parmele June 26, 1964
You will, pay us for-this study as follows: $1, 000. per month
for the first three months, and $500. per month, for the fourth, fifth
and sixth month. The experiment will be terminated after a total of
six months (24 weeks). We shall bill you monthly in advance beginning
now, since we have already spent some professional and technical! time
on this project.
In view of the urgent nature of these studies, we shall~ report to
you by telephone whenever the results appear interesting, and we shall
report in the form of tumor incidence graphs at frequent intervals as
soon as a significant number of tumors will appear.
Dr. Kelley is enclosing a report to you on some of the polonium
s tudie s .
Yours sincerely,
F,reddy Hoinburger, M, D.
President and Director
FH:er
